• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经内分泌肿瘤活检与切除标本中Ki-67指数的相关性

Correlation of Ki-67 indices from biopsy and resection specimens of neuroendocrine tumours.

作者信息

Barnes J, Johnson S J, French J J

机构信息

Newcastle upon Tyne Hospitals NHS Foundation Trust , UK.

出版信息

Ann R Coll Surg Engl. 2017 Mar;99(3):193-197. doi: 10.1308/rcsann.2016.0225. Epub 2016 Aug 4.

DOI:10.1308/rcsann.2016.0225
PMID:27490982
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5450268/
Abstract

INTRODUCTION Neuroendocrine tumours (NETs) are a heterogeneous group of tumours with a highly variable presentation and prognosis. Management decisions are complex. Ki-67 levels in tissue samples are a key indicator used to grade tumours and guide treatment. This study assessed whether the Ki-67 index and tumour grade generated from tissue samples correlated with that assessed in resection specimens. METHODS This was a retrospective cohort analysis of all patients who had both a tissue sample and a resection specimen analysed in our trust, a tertiary referral centre, during 2012 and 2013. RESULTS Data from 36 patients were reviewed. Ki-67 indices from tissue samples and resection specimens showed strong correlation (r=0.95, p<0.001). Tumour grading was the same in the tissue sample and resection specimens for 22 patients (61.1%). In four patients (11.1%), the tissue sample overestimated the grade while in ten (27.8%), the sample underestimated the grade. CONCLUSIONS In most cases, the Ki-67 index and tumour grade from the tissue sample matched that of the resection specimen. However, in nearly 40% of cases, the tissue sample grading did not match the resection tumour grading. In the majority of these, the tissue sample underestimated disease activity. A low Ki-67 index in a tissue sample should therefore be taken as provisional and should not, in isolation, persuade clinicians to choose a more conservative treatment approach if there is clinical, biochemical or radiological evidence suggestive of a more aggressive disease pathology.

摘要

引言

神经内分泌肿瘤(NETs)是一组异质性肿瘤,其临床表现和预后差异很大。治疗决策复杂。组织样本中的Ki-67水平是用于肿瘤分级和指导治疗的关键指标。本研究评估了组织样本中的Ki-67指数和肿瘤分级与切除标本中评估的结果是否相关。

方法

这是一项回顾性队列分析,研究对象为2012年至2013年期间在我们医院(一家三级转诊中心)接受组织样本和切除标本分析的所有患者。

结果

对36例患者的数据进行了回顾。组织样本和切除标本的Ki-67指数显示出强烈相关性(r=0.95,p<0.001)。22例患者(61.1%)的组织样本和切除标本中的肿瘤分级相同。4例患者(11.1%)的组织样本高估了分级,10例患者(27.8%)的样本低估了分级。

结论

在大多数情况下,组织样本中的Ki-67指数和肿瘤分级与切除标本中的相符。然而,在近40%的病例中,组织样本分级与切除肿瘤分级不匹配。在大多数此类病例中,组织样本低估了疾病活动度。因此,如果有临床、生化或放射学证据提示疾病病理更具侵袭性,组织样本中低Ki-67指数应视为初步结果,不应仅凭此说服临床医生选择更保守的治疗方法。

相似文献

1
Correlation of Ki-67 indices from biopsy and resection specimens of neuroendocrine tumours.神经内分泌肿瘤活检与切除标本中Ki-67指数的相关性
Ann R Coll Surg Engl. 2017 Mar;99(3):193-197. doi: 10.1308/rcsann.2016.0225. Epub 2016 Aug 4.
2
Can pancreatic neuroendocrine tumour biopsy accurately determine pathological characteristics?胰腺神经内分泌肿瘤活检能否准确确定病理特征?
Dig Liver Dis. 2015 Nov;47(11):973-7. doi: 10.1016/j.dld.2015.06.005. Epub 2015 Jun 20.
3
Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective study.EUS 引导下细针组织获取的组织样本中 Ki-67 分级在非功能性胰腺神经内分泌肿瘤中的应用:一项前瞻性研究。
Gastrointest Endosc. 2012 Sep;76(3):570-7. doi: 10.1016/j.gie.2012.04.477.
4
The value of the Ki-67 proliferation marker as a prognostic factor in gastroenteropancreatic neuroendocrine tumours.Ki-67 增殖标志物在胃肠胰神经内分泌肿瘤中的预后价值。
Endokrynol Pol. 2012;63(5):362-6.
5
Role of Ki-67 proliferation index in the assessment of patients with neuroendocrine neoplasias regarding the stage of disease.Ki-67增殖指数在评估神经内分泌肿瘤患者疾病分期中的作用。
World J Surg. 2014 Jun;38(6):1353-61. doi: 10.1007/s00268-014-2451-0.
6
Pancreatic neuroendocrine tumors: accurate grading with Ki-67 index on fine-needle aspiration specimens using the WHO 2010/ENETS criteria.胰腺神经内分泌肿瘤:使用 WHO 2010/ENETS 标准,通过细针穿刺标本中的 Ki-67 指数进行准确分级。
Cancer Cytopathol. 2014 Oct;122(10):770-8. doi: 10.1002/cncy.21457. Epub 2014 Jul 9.
7
Grading by the Ki-67 Labeling Index of Endoscopic Ultrasound-Guided Fine Needle Aspiration Biopsy Specimens of Pancreatic Neuroendocrine Tumors Can Be Underestimated.通过Ki-67标记指数对胰腺神经内分泌肿瘤的内镜超声引导下细针穿刺活检标本进行分级可能会被低估。
Pancreas. 2018 Nov/Dec;47(10):1296-1303. doi: 10.1097/MPA.0000000000001157.
8
Accuracy of grading pancreatic neuroendocrine neoplasms with Ki-67 index in fine-needle aspiration cellblock material.在细针穿刺细胞块材料中用Ki-67指数对胰腺神经内分泌肿瘤进行分级的准确性。
Cytopathology. 2019 Mar;30(2):187-193. doi: 10.1111/cyt.12643. Epub 2018 Nov 28.
9
Pancreatic neuroendocrine tumour grading on endoscopic ultrasound-guided fine needle aspiration: high reproducibility and inter-observer agreement of the Ki-67 labelling index.内镜超声引导下细针穿刺活检对胰腺神经内分泌肿瘤的分级:Ki-67标记指数具有高度可重复性和观察者间一致性。
Cytopathology. 2014 Dec;25(6):389-95. doi: 10.1111/cyt.12111. Epub 2013 Nov 15.
10
Improving fine needle aspiration to predict the tumor biological aggressiveness in pancreatic neuroendocrine tumors using Ki-67 proliferation index, phosphorylated histone H3 (PHH3), and BCL-2.利用 Ki-67 增殖指数、磷酸化组蛋白 H3(PHH3)和 BCL-2 提高细针抽吸术对胰腺神经内分泌肿瘤肿瘤生物学侵袭性的预测能力。
Ann Diagn Pathol. 2023 Aug;65:152149. doi: 10.1016/j.anndiagpath.2023.152149. Epub 2023 Apr 21.

引用本文的文献

1
Tumour Heterogeneity and the Consequent Practical Challenges in the Management of Gastroenteropancreatic Neuroendocrine Neoplasms.肿瘤异质性以及胃肠胰神经内分泌肿瘤管理中随之而来的实际挑战
Cancers (Basel). 2023 Mar 20;15(6):1861. doi: 10.3390/cancers15061861.
2
Evaluation of treatment delays in hepatopancreatico-biliary surgery during the first COVID-19 wave.评估 COVID-19 第一波期间肝胆胰手术的治疗延迟。
Ann R Coll Surg Engl. 2023 Aug;105(S2):S12-S17. doi: 10.1308/rcsann.2021.0317. Epub 2022 Feb 17.
3
Current Practices and Novel Techniques in the Diagnosis and Management of Neuroendocrine Tumors of Unknown Primary.原发不明神经内分泌肿瘤的诊断和治疗的当前实践和新方法。
Pancreas. 2019 Oct;48(9):1111-1118. doi: 10.1097/MPA.0000000000001391.
4
Tumor growth rate as a metric of progression, response, and prognosis in pancreatic and intestinal neuroendocrine tumors.肿瘤生长率作为胰腺和肠神经内分泌肿瘤进展、反应和预后的指标。
BMC Cancer. 2019 Jan 14;19(1):66. doi: 10.1186/s12885-018-5257-x.
5
Classification of pulmonary neuroendocrine tumors: new insights.肺神经内分泌肿瘤的分类:新见解
Transl Lung Cancer Res. 2017 Oct;6(5):513-529. doi: 10.21037/tlcr.2017.09.04.

本文引用的文献

1
Pancreatic neuroendocrine tumour grading on endoscopic ultrasound-guided fine needle aspiration: high reproducibility and inter-observer agreement of the Ki-67 labelling index.内镜超声引导下细针穿刺活检对胰腺神经内分泌肿瘤的分级:Ki-67标记指数具有高度可重复性和观察者间一致性。
Cytopathology. 2014 Dec;25(6):389-95. doi: 10.1111/cyt.12111. Epub 2013 Nov 15.
2
Diagnosis and treatment of neuroendocrine lung tumors.神经内分泌性肺肿瘤的诊断与治疗
Arch Bronconeumol. 2014 Sep;50(9):392-6. doi: 10.1016/j.arbres.2014.02.004. Epub 2014 Mar 28.
3
Incidence of gastroenteropancreatic neuroendocrine tumours: a systematic review of the literature.胃肠胰神经内分泌肿瘤的发病率:文献系统综述。
Endocr Relat Cancer. 2014 May 6;21(3):R153-63. doi: 10.1530/ERC-13-0125. Print 2014 Jun.
4
[Gastroenteropancreatic neuroendocrine neoplasms. Role of biopsies].[胃肠胰神经内分泌肿瘤。活检的作用]
Pathologe. 2013 Nov;34 Suppl 2:221-5. doi: 10.1007/s00292-013-1872-0.
5
Endoscopic treatment for early foregut neuroendocrine tumors.早期前肠神经内分泌肿瘤的内镜治疗
Clin Endosc. 2013 Sep;46(5):450-5. doi: 10.5946/ce.2013.46.5.450. Epub 2013 Sep 30.
6
Gastrointestinal carcinoid: epidemiological and survival evidence from a large population-based study (n = 25 531).胃肠道类癌:一项基于大样本的流行病学和生存证据研究(n = 25531)。
Ann Oncol. 2013 Dec;24(12):3040-4. doi: 10.1093/annonc/mdt377. Epub 2013 Sep 19.
7
Chromogranin A, Ki-67 index and IGF-related genes in patients with neuroendocrine tumors.神经内分泌肿瘤患者的嗜铬粒蛋白 A、Ki-67 指数和 IGF 相关基因。
Endocr Connect. 2013 Dec 1;2(4):172-7. doi: 10.1530/EC-13-0052. Print 2013.
8
Prognostic factors and long-term outcome of pancreatic neuroendocrine neoplasms: Ki-67 index shows a greater impact on survival than disease stage. The large experience of the Spanish National Tumor Registry (RGETNE).胰腺神经内分泌肿瘤的预后因素和长期结果:Ki-67 指数对生存的影响大于疾病分期。西班牙国家肿瘤登记处(RGETNE)的丰富经验。
Neuroendocrinology. 2013;98(2):156-68. doi: 10.1159/000355152. Epub 2013 Sep 19.
9
Advancements in pancreatic neuroendocrine tumors.胰腺神经内分泌肿瘤的进展。
Expert Rev Gastroenterol Hepatol. 2013 Jul;7(5):477-90. doi: 10.1586/17474124.2013.811058.
10
Accuracy of visual assessments of proliferation indices in gastroenteropancreatic neuroendocrine tumours.胃胰肠神经内分泌肿瘤增殖指数的视觉评估准确性。
J Clin Pathol. 2013 Aug;66(8):700-4. doi: 10.1136/jclinpath-2012-201217. Epub 2013 May 23.